Annual FCF
-$67.76 M
-$14.73 M-27.77%
30 June 2022
Summary:
Applied Genetic Technologies annual free cash flow is currently -$67.76 million, with the most recent change of -$14.73 million (-27.77%) on 30 June 2022. During the last 3 years, it has fallen by -$14.73 million (-27.77%).AGTC Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$16.34 M
+$2.78 M+14.53%
30 September 2022
Summary:
Applied Genetic Technologies quarterly free cash flow is currently -$16.34 million, with the most recent change of +$2.78 million (+14.53%) on 30 September 2022.AGTC Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$67.55 M
+$210.00 K+0.31%
30 September 2022
Summary:
Applied Genetic Technologies TTM free cash flow is currently -$67.55 million, with the most recent change of +$210.00 thousand (+0.31%) on 30 September 2022.AGTC TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AGTC Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -27.8% | +1.3% | -20.8% |
| 5 y5 years | -185.1% | -47.5% | -91.0% |
AGTC Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -199.1% | -117.2% | -185.3% |
Applied Genetic Technologies Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$16.34 M(-14.5%) | -$67.55 M(-0.3%) |
| June 2022 | -$67.76 M(+27.8%) | -$19.12 M(+34.6%) | -$67.76 M(+8.3%) |
| Mar 2022 | - | -$14.20 M(-20.6%) | -$62.59 M(+4.0%) |
| Dec 2021 | - | -$17.89 M(+8.1%) | -$60.19 M(+7.7%) |
| Sept 2021 | - | -$16.55 M(+18.7%) | -$55.91 M(+5.4%) |
| June 2021 | -$53.03 M(+23.9%) | -$13.95 M(+18.2%) | -$53.03 M(+0.3%) |
| Mar 2021 | - | -$11.80 M(-13.3%) | -$52.89 M(+5.0%) |
| Dec 2020 | - | -$13.61 M(-0.5%) | -$50.38 M(+10.9%) |
| Sept 2020 | - | -$13.68 M(-0.9%) | -$45.42 M(+6.1%) |
| June 2020 | -$42.82 M(+80.1%) | -$13.80 M(+48.6%) | -$42.82 M(+16.9%) |
| Mar 2020 | - | -$9.29 M(+7.4%) | -$36.63 M(+6.6%) |
| Dec 2019 | - | -$8.65 M(-21.9%) | -$34.37 M(-2.8%) |
| Sept 2019 | - | -$11.08 M(+45.4%) | -$35.36 M(+48.8%) |
| June 2019 | -$23.77 M(-28.7%) | -$7.62 M(+8.5%) | -$23.77 M(+3.2%) |
| Mar 2019 | - | -$7.02 M(-27.2%) | -$23.04 M(-3.2%) |
| Dec 2018 | - | -$9.64 M(-1958.2%) | -$23.81 M(-0.9%) |
| Sept 2018 | - | $519.00 K(-107.5%) | -$24.02 M(-27.9%) |
| June 2018 | -$33.32 M(+4.5%) | -$6.89 M(-11.6%) | -$33.32 M(-9.0%) |
| Mar 2018 | - | -$7.80 M(-20.9%) | -$36.62 M(-1.2%) |
| Dec 2017 | - | -$9.85 M(+12.2%) | -$37.08 M(+6.5%) |
| Sept 2017 | - | -$8.78 M(-13.9%) | -$34.81 M(+9.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2017 | -$31.89 M(-146.6%) | -$10.19 M(+23.5%) | -$31.89 M(+8.7%) |
| Mar 2017 | - | -$8.26 M(+8.9%) | -$29.35 M(-5.6%) |
| Dec 2016 | - | -$7.58 M(+29.2%) | -$31.10 M(-3.9%) |
| Sept 2016 | - | -$5.87 M(-23.3%) | -$32.37 M(-147.3%) |
| June 2016 | $68.40 M(-445.3%) | -$7.65 M(-23.6%) | $68.40 M(-1.7%) |
| Mar 2016 | - | -$10.01 M(+13.1%) | $69.61 M(-6.7%) |
| Dec 2015 | - | -$8.85 M(-109.3%) | $74.60 M(-5.8%) |
| Sept 2015 | - | $94.90 M(-1573.9%) | $79.21 M(-499.9%) |
| June 2015 | -$19.81 M(+61.0%) | -$6.44 M(+28.3%) | -$19.81 M(+20.5%) |
| Mar 2015 | - | -$5.02 M(+18.5%) | -$16.43 M(+9.0%) |
| Dec 2014 | - | -$4.23 M(+2.8%) | -$15.08 M(+4.8%) |
| Sept 2014 | - | -$4.12 M(+34.4%) | -$14.39 M(+16.9%) |
| June 2014 | -$12.30 M(+271.9%) | -$3.06 M(-16.3%) | -$12.30 M(+29.5%) |
| Mar 2014 | - | -$3.66 M(+3.4%) | -$9.50 M(+27.1%) |
| Dec 2013 | - | -$3.54 M(+74.0%) | -$7.47 M(+51.7%) |
| Sept 2013 | - | -$2.04 M(+683.1%) | -$4.92 M(+48.9%) |
| June 2013 | -$3.31 M(+123.5%) | -$260.00 K(-84.1%) | -$3.31 M(+8.5%) |
| Mar 2013 | - | -$1.63 M(+64.2%) | -$3.05 M(+115.6%) |
| Dec 2012 | - | -$995.00 K(+137.5%) | -$1.41 M(+237.5%) |
| Sept 2012 | - | -$419.00 K | -$419.00 K |
| June 2012 | -$1.48 M | - | - |
FAQ
- What is Applied Genetic Technologies annual free cash flow?
- What is the all time high annual FCF for Applied Genetic Technologies?
- What is Applied Genetic Technologies quarterly free cash flow?
- What is the all time high quarterly FCF for Applied Genetic Technologies?
- What is Applied Genetic Technologies TTM free cash flow?
- What is the all time high TTM FCF for Applied Genetic Technologies?
What is Applied Genetic Technologies annual free cash flow?
The current annual FCF of AGTC is -$67.76 M
What is the all time high annual FCF for Applied Genetic Technologies?
Applied Genetic Technologies all-time high annual free cash flow is $68.40 M
What is Applied Genetic Technologies quarterly free cash flow?
The current quarterly FCF of AGTC is -$16.34 M
What is the all time high quarterly FCF for Applied Genetic Technologies?
Applied Genetic Technologies all-time high quarterly free cash flow is $94.90 M
What is Applied Genetic Technologies TTM free cash flow?
The current TTM FCF of AGTC is -$67.55 M
What is the all time high TTM FCF for Applied Genetic Technologies?
Applied Genetic Technologies all-time high TTM free cash flow is $79.21 M